Older Men Are as Responsive as Young Men to the Anabolic Effects of Graded Doses of Testosterone on the Skeletal Muscle
The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.
Abstract
Although testosterone levels and muscle mass decline with age, many older men have serum testosterone level in the normal range, leading to speculation about whether older men are less sensitive to testosterone. We determined the responsiveness of androgen-dependent outcomes to graded testosterone doses in older men and compared it to that in young men. The participants in this randomized, double-blind trial were 60 ambulatory, healthy, older men, 60-75 yr of age, who had normal serum testosterone levels. Their responses to graded doses of testosterone were compared with previous data in 61 men, 19-35 yr old. The participants received a long-acting GnRH agonist to suppress endogenous testosterone production and 25, 50, 125, 300, or 600 mg testosterone enanthate weekly for 20 wk. Fat-free mass, fat mass, muscle strength, sexual function, mood, visuospatial cognition, hormone levels, and safety measures were evaluated before, during, and after treatment. Of 60 older men who were randomized, 52 completed the study. After adjusting for testosterone dose, changes in serum total testosterone (change, -6.8, -1.9, +16.1, +49.5, and +101.9 nmol/liter at 25, 50, 125, 300, and 600 mg/wk, respectively) and hemoglobin (change, -3.6, +9.9, +20.9, +12.6, and +29.4 g/liter at 25, 50, 125, 300, and 600 mg/wk, respectively) levels were dose-related in older men and significantly greater in older men than young men (each P < 0.0001). The changes in FFM (-0.3, +1.7, +4.2, +5.6, and +7.3 kg, respectively, in five ascending dose groups) and muscle strength in older men were correlated with testosterone dose and concentrations and were not significantly different in young and older men. Changes in fat mass correlated inversely with testosterone dose (r = -0.54; P < 0.001) and were significantly different in young vs. older men (P < 0.0001); young men receiving 25- and 50-mg doses gained more fat mass than older men (P < 0.0001). Mood and visuospatial cognition did not change significantly in either group. Frequency of hematocrit greater than 54%, leg edema, and prostate events were numerically higher in older men than in young men. Older men are as responsive as young men to testosterone's anabolic effects; however, older men have lower testosterone clearance rates, higher increments in hemoglobin, and a higher frequency of adverse effects. Although substantial gains in muscle mass and strength can be realized in older men with supraphysiological testosterone doses, these high doses are associated with a high frequency of adverse effects. The best trade-off was achieved with a testosterone dose (125 mg) that was associated with high normal testosterone levels, low frequency of adverse events, and significant gains in fat-free mass and muscle strength.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are conflicting data on the effect of testosterone supplementation on muscle strength and function50,51,357,414.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [414]
In the citing paper
“Testosterone has a dose-dependent impact on fat-free mass in both the young and old, with higher levels associated with reduction in fat mass and increase in skeletal muscle mass and strength [43].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [43]
Citations
Cites
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350101 · Cited by 1,659
Self-citationAging of skeletal muscle: a 12-yr longitudinal study
Frontera, W. R., Hughes, V. A., Fielding, R. A., Fiatarone, M. A., Evans, W. J., & Roubenoff, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1321 · Cited by 1,443
GRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 7×
“The characteristics of young men have been described previously (29).”
BackgroundMethodResultInfluentialSelf-citationTestosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.6.1661 · Cited by 922
Hughes, V. A., Frontera, W. R., Wood, M., Evans, W. J., Dallal, G. E., Roubenoff, R., & Singh, M. A. F. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.5.b209 · Cited by 921
Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women
Iannuzzi-Sucich, M., Prestwood, K. M., & Kenny, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.12.m772 · Cited by 890
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Cited by
Spruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Self-citationBhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
“Testosterone administration in hypogonadal men is associated with a dose-dependent increase in hemoglobin levels (109–111); the increase in hemoglobin is greater in older men than in young hypogonadal men (110, 111).”
BackgroundSelf-citationTestosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736
“The effects of T on muscle/fat mass and muscle strength are related to the administered dose and increase in circulating T concentrations (75 – 77).”
Self-citationIdentification of late-onset hypogonadism in middle-aged and elderly men
Wu, F. C. W., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911101 · Cited by 1,544
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Self-citationSarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Ries, A. L., Bauldoff, G. S., Carlin, B. W., Casaburi, R., Emery, C. F., Mahler, D. A., Make, B., Rochester, C. L., ZuWallack, R., & Herrerias, C. (2007) · Chest · doi:10.1378/chest.06-2418 · Cited by 1,306
Self-citationMaltais, F., Decramer, M., Casaburi, R., Barreiro, E., Burelle, Y., Debigaré, R., Dekhuijzen, P. N. R., Franssen, F., Gayan-Ramirez, G., Gea, J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0373st · Cited by 1,090
Self-citationThe Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
“(427) observed a higher incidence of erythrocytosis, leg edema, and prostate events in the elderly, whereas the young had more frequently Kaufman and Vermeulen • Androgen Decline in Elderly Men Endocrine Reviews, October 2005, 26(6):833–876 861”
BackgroundBhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
“Testosterone administration in hypogonadal men is associated with a dosedependent increase in hemoglobin levels (39); the increase in hemoglobin is greater in older men than in young hypogonadal men (40).”
BackgroundSelf-citationISSN exercise & sports nutrition review update: research & recommendations
Kerksick, C. M., Wilborn, C. D., Roberts, M. D., Smith-Ryan, A., Kleiner, S. M., Jäger, R., Collins, R., Cooke, M., Davis, J. N., Galvan, E., et al. (2018) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-018-0242-y · Cited by 945
Clark, B. C., & Manini, T. M. (2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.8.829 · Cited by 835
Estrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860
Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men
Finkelstein, J. S., Lee, H., Burnett-Bowie, S.-A. M., Pallais, J. C., Yu, E. W., Borges, L. F., Jones, B. F., Barry, C. V., Wulczyn, K. E., Thomas, B. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1206168 · Cited by 782
Women's underrepresentation in science: sociocultural and biological considerations
Ceci, S. J., Williams, W. M., & Barnett, S. M. (2009) · Psychological Bulletin · doi:10.1037/a0014412 · Cited by 957
“Bhasin and colleagues’ conclusion about the lack of a dose-dependent relationship between testosterone and visual–spatial memory (for a review, see Bhasin et al., 2005) seems prudent: “Although men, on average, perform better on tests of spatial cognition than women, testosterone replacement has…”
BackgroundSrinivas-Shankar, U., Roberts, S. A., Connolly, M. J., O'Connell, M. D. L., Adams, J. E., Oldham, J. A., & Wu, F. C. W. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1251 · Cited by 629
Tajar, A., Forti, G., O'Neill, T. W., Lee, D. M., Silman, A. J., Finn, J. D., Bartfai, G., Boonen, S., Casanueva, F. F., Giwercman, A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1796 · Cited by 604
Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance
Handelsman, D. J., Hirschberg, A. L., & Bermon, S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00020 · Cited by 594
Kelly, D. M., & Jones, T. H. (2015) · Obesity Reviews · doi:10.1111/obr.12282 · Cited by 487
“(133) Injectable TE Healthy older men 20 weeks ND ND ND ↑ ↓”
BackgroundMorgentaler, A., & Traish, A. M. (2009) · European Urology · doi:10.1016/j.eururo.2008.09.024 · Cited by 462
ISSN exercise & sport nutrition review: research & recommendations
Kreider, R. B., Wilborn, C. D., Taylor, L., Campbell, B., Almada, A. L., Collins, R., Cooke, M., Earnest, C. P., Greenwood, M., Kalman, D. S., et al. (2010) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-7-7 · Cited by 428
“, anabolism) and strength while decreasing muscle breakdown (catabolism) and fat mass [197-204].”
BackgroundEffects of graded doses of testosterone on erythropoiesis in healthy young and older men
Coviello, A. D., Kaplan, B., Lakshman, K. M., Chen, T., Singh, A. B., & Bhasin, S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1692 · Cited by 404
Functional consequences of sarcopenia and dynapenia in the elderly
Clark, B. C., & Manini, T. M. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328337819e · Cited by 359
Evolution in Health and Disease
(2007) · doi:10.1093/acprof:oso/9780199207466.001.0001 · Cited by 320
Sinha-Hikim, I., Cornford, M., Gaytan, H., Lee, M. L., & Bhasin, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0357 · Cited by 318
“Because muscle satellite cells play an important role in mediating the hypertrophic response to anabolic stimulus and muscle injury, we determined the effects of testosterone administration on satellite cell number in older men in muscle biopsies obtained during the course of a testosterone doseresponse study (14).”
InfluentialSelf-citationTajar, A., Huhtaniemi, I. T., O'Neill, T. W., Finn, J. D., Pye, S. R., Lee, D. M., Bartfai, G., Boonen, S., Casanueva, F. F. F., Forti, G., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2513 · Cited by 318
Bhasin, S., Calof, O. M., Storer, T. W., Lee, M. L., Mazer, N. A., Jasuja, R., Montori, V. M., Gao, W., & Dalton, J. T. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0120 · Cited by 300
“The gains in FFM, muscle size, and muscle strength in response to testosterone administration correlate with increasing testosterone dose and circulating testosterone concentrations”
BackgroundSelf-citationAllan, C. A., Strauss, B. J. G., Burger, H. G., Forbes, E. A., & McLachlan, R. I. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1291 · Cited by 298
“Similar effects on FFM have been reported in healthy older men (with comparable baseline FFM) rendered hypogonadal with a GnRH agonist and then given exogenous testosterone to return serum TT to baseline levels for 20 wk (38).”
BackgroundLow Testosterone Levels and the Risk of Anemia in Older Men and Women
Ferrucci, L., Maggio, M., Bandinelli, S., Basaria, S., Lauretani, F., Ble, A., Valenti, G., Ershler, W. B., Guralnik, J. M., & Longo, D. L. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.13.1380 · Cited by 272
Kenny, A. M., Kleppinger, A., Annis, K., Rathier, M., Browner, B., Judge, J. O., & McGee, D. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02865.x · Cited by 252
“A favorable effect due to inadequate increases in testosterone levels may have been missed, because a dose response of muscle to testosterone has been demonstrated.(19) Of the few trials of older men treated with testosterone, only two have demonstrated an increase in hand muscle strength,(2,20) and none has demonstra…”
BackgroundBachman, E., Feng, R., Travison, T., Li, M., Olbina, G., Ostland, V., Ulloor, J., Zhang, A., Basaria, S., Ganz, T., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0864 · Cited by 247
Self-citationHormone Therapy and Skeletal Muscle Strength: A Meta-Analysis
Greising, S. M., Baltgalvis, K. A., Lowe, D. A., & Warren, G. L. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glp082 · Cited by 242
Pharmacologic Options for the Treatment of Sarcopenia
Morley, J. E. (2016) · Calcified Tissue International · doi:10.1007/s00223-015-0022-5 · Cited by 225
“terone increased muscle mass and decreases fat mass [95] and in higher doses increased both muscle and power [96].”
BackgroundAndrogens and erythropoiesis: past and present
Shahani, S., Braga-Basaria, M., Maggio, M., & Basaria, S. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345745 · Cited by 231
Selective androgen receptor modulators as function promoting therapies
Bhasin, S., & Jasuja, R. (2009) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32832a3d79 · Cited by 216
Self-citationEndocrine Aspects of Male Sexual Dysfunctions
Buvat, J., Maggi, M., Gooren, L., Guay, A. T., Kaufman, J., Morgentaler, A., Schulman, C., Tan, H. M., Torres, L. O., Yassin, A., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01780.x · Cited by 221
Zitzmann, M., & Nieschlag, E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0620 · Cited by 216
MacLean, H. E., Chiu, W. S. M., Notini, A. J., Axell, A.-M., Davey, R. A., McManus, J. F., Ma, C., Plant, D. R., Lynch, G. S., & Zajac, J. D. (2008) · The FASEB Journal · doi:10.1096/fj.08-105726 · Cited by 209
Mohler, M. L., Bohl, C. E., Jones, A., Coss, C. C., Narayanan, R., He, Y., Hwang, D. J., Dalton, J. T., & Miller, D. D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900280m · Cited by 205
Testosterone for the aging male; current evidence and recommended practice
Jones, H. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s190 · Cited by 204
“A given testosterone dose produced higher serum concentrations of testosterone in the older age group (Bhasin et al 2005).”
InfluentialGray, P. B., Singh, A. B., Woodhouse, L. J., Storer, T. W., Casaburi, R., Dzekov, J., Dzekov, C., Sinha-Hikim, I., & Bhasin, S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0247 · Cited by 202
“Free testosterone was separated by an equilibrium dialysis procedure and was measured by RIA (30).”
BackgroundMethodInfluentialSelf-citationTestosterone Supplementation in Heart Failure: A Meta-Analysis
Toma, M., McAlister, F. A., Coglianese, E. E., Vidi, V., Vasaiwala, S., Bakal, J. A., Armstrong, P. W., & Ezekowitz, J. A. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.965632 · Cited by 200
Dubois, V., Laurent, M., Boonen, S., Vanderschueren, D., & Claessens, F. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0883-3 · Cited by 197
Bone and muscle loss after spinal cord injury: organ interactions
Qin, W., Bauman, W. A., & Cardozo, C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05806.x · Cited by 189
Endogenous Testosterone Levels, Physical Performance, and Fall Risk in Older Men
Orwoll, E. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2124 · Cited by 189
Skeletal muscle and bone: effect of sex steroids and aging
Brown, M. (2008) · Advances in Physiology Education · doi:10.1152/advan.90111.2008 · Cited by 189
“(4) administered graded doses of testosterone for 20 wk to 60 older men (60–75 yr) who were made hypogonadal following GnRH administration.”
BackgroundAnabolic–androgenic steroids: How do they work and what are the risks?
Bond, P., Smit, D. L., & de Ronde, W. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1059473 · Cited by 184
“Supraphysiological dosages of testosterone, at least up to 600 mg testosterone enanthate, did not affect serum prostate-specific antigen (PSA) levels in both healthy young (15, 22) and older men (37).”
BackgroundResultDHEA, Important Source of Sex Steroids in Men and Even More in Women
Labrie, F. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)82004-7 · Cited by 183
Storer, T. W., Basaria, S., Traustadottir, T., Harman, S. M., Pencina, K., Li, Z., Travison, T. G., Miciek, R., Tsitouras, P., Hally, K., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2771 · Cited by 174
“Indeed, in our previous dose-response studies, substantially larger gains in lean body mass with higher doses of testosterone than those used in this trial were associated with substantially greater increments in leg-press strength (3).”
BackgroundResultSelf-citation(2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.2.160 · Cited by 172
“For example, testosterone is highly effective at increasing muscle size and strength in older men (44), but the effects of these changes on functional capacity or mobility are unknown.”
BackgroundAllan, C. A., & McLachlan, R. I. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283398ee2 · Cited by 168
Giannoulis, M. G., Sonksen, P. H., Umpleby, M., Breen, L., Pentecost, C., Whyte, M., McMillan, C. V., Bradley, C., & Martin, F. C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0957 · Cited by 164
“The absence of significant LBM or fat changes on Te alone differs from previous studies of elderly or hypogonadal men (16, 17, 30).”
Resultthe Sarcopenia Guidelines Development group of the Belgian Society of Gerontology and Geriatrics (BSGG), De Spiegeleer, A., Beckwée, D., Bautmans, I., & Petrovic, M. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0566-y · Cited by 160
Travison, T. G., Basaria, S., Storer, T. W., Jette, A. M., Miciek, R., Farwell, W. R., Choong, K., Lakshman, K., Mazer, N. A., Coviello, A. D., et al. (2011) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr100 · Cited by 160
“Sex hormone binding globulin levels were measured using an immunofluorometric assay with sensitivity 2.5 nmol/L (DELFIA-Wallac, Turku, Finland) (8,13,23).”
Self-citationModifying muscle mass – the endocrine perspective
Solomon, A. M., & Bouloux, P. M. G. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06837 · Cited by 156
“More recently, effects have also been observed in older subjects, albeit of reduced magnitude (Bhasin et al. 2001, 2005).”
BackgroundKrasnoff, J. B., Basaria, S., Pencina, M. J., Jasuja, G. K., Vasan, R. S., Ulloor, J., Zhang, A., Coviello, A., Kelly-Hayes, M., D'Agostino, R. B., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2680 · Cited by 152
Self-citationBhasin, S., Travison, T. G., Storer, T. W., Lakshman, K., Kaushik, M., Mazer, N. A., Ngyuen, A.-H., Davda, M. N., Jara, H., Aakil, A., et al. (2012) · JAMA · doi:10.1001/jama.2012.227 · Cited by 152
“Low-density lipoprotein 121 (19) 112 (30) 108 (34) 120 (37) 105 (27) 104 (36) 93 (23) 112 (28)”
Self-citationBasaria, S., Collins, L., Dillon, E. L., Orwoll, K., Storer, T. W., Miciek, R., Ulloor, J., Zhang, A., Eder, R., Zientek, H., et al. (2013) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gls078 · Cited by 150
Self-citationJung, H. N., Jung, C. H., & Hwang, Y. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155557 · Cited by 184
Nielsen, T. L., Hagen, C., Wraae, K., Brixen, K., Petersen, P. H., Haug, E., Larsen, R., & Andersen, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1847 · Cited by 149
Surampudi, P. N., Wang, C., & Swerdloff, R. (2012) · International Journal of Endocrinology · doi:10.1155/2012/625434 · Cited by 149
“Intramuscular injections of testosterone can cause local reactions such as soreness, erythema, and bruising [224, 225].”
BackgroundPhysiological Basis of Fatigue
Evans, W. J., & Lambert, C. P. (2007) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e31802ba53c · Cited by 146
“examined 9 wks of resistance exercise training and the use of albuterol (16 mg/day) or a placebo in healthy young subjects.(15,103,104,135,23,24,27,93,110,144) Albuterol combined with resistance training improved strength to a greater extent than resistance training alone.”
BackgroundStorer, T. W., Woodhouse, L., Magliano, L., Singh, A. B., Dzekov, C., Dzekov, J., & Bhasin, S. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01927.x · Cited by 145
“Hormone Assays Serum testosterone (immunoassay) and free testosterone (equilibrium dialysis) were measured as previously reported.(9,11) The sensitivities, and intra- and interassay coefficients of variation of these assays were 0.”
MethodSelf-citationAging and the Male Reproductive System
Kaufman, J.-M., Lapauw, B., Mahmoud, A., T’Sjoen, G., & Huhtaniemi, I. T. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00178 · Cited by 144
Sarcopenic obesity: how do we treat it?
Bouchonville, M. F., & Villareal, D. T. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/01.med.0000433071.11466.7f · Cited by 141
“Similarly, other studies in healthy older men have reported favorable effects of testosterone therapy on body composition [74,75].”
Sex differences in athletic performance emerge coinciding with the onset of male puberty
Handelsman, D. J. (2017) · Clinical Endocrinology · doi:10.1111/cen.13350 · Cited by 142
Hypogonadism, Quadriceps Weakness, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease
van Vliet, M., Spruit, M. A., Verleden, G. M., Kasran, A., Herck, E. V., Pitta, F. D. O., Bouillon, R., & Decramer, M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200501-114oc · Cited by 153
Hildreth, K. L., Barry, D. W., Moreau, K. L., Vande Griend, J., Meacham, R. B., Nakamura, T., Wolfe, P., Kohrt, W. M., Ruscin, J. M., Kittelson, J., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3695 · Cited by 140
“This may reflect the higher level of regular exercise of the lower body in healthy older adults, However, Bhasin et al (32) found improvements in leg press strength in healthy older men that were correlated with both T dose and level.”
BackgroundShin, M. J., Jeon, Y. K., & Kim, I. J. (2018) · The World Journal of Men's Health · doi:10.5534/wjmh.180001 · Cited by 134
“These data showed moderate efficacy in muscle strength, not only for the hypogonadal men but also in eugonadal older men or healthy young normal men who underwent supplementation of testosterone in various concentrations [41].”
BackgroundPosition Stand on Androgen and Human Growth Hormone Use
Hoffman, J. R., Kraemer, W. J., Bhasin, S., Storer, T., Ratamess, N. A., Haff, G. G., Willoughby, D. S., & Rogol, A. D. (2009) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e31819df2e6 · Cited by 139
“(68) administered 25, 50, 125, 300, or 600 mg wk(21) of testosterone enanthate to elderly men over 20 weeks and reported that increases in lean body mass correlated to the dose administered.”
BackgroundSelf-citationHormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones?
Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M., & Sonksen, P. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1002 · Cited by 132
Ostrowski, J., Kuhns, J. E., Lupisella, J. A., Manfredi, M. C., Beehler, B. C., Krystek, S. R., Bi, Y., Sun, C., Seethala, R., Golla, R., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0843 · Cited by 137
Morley, J. E., Haren, M. T., Rolland, Y., & Kim, M. J. (2006) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.05.019 · Cited by 170
Verdijk, L. B., Snijders, T., Beelen, M., Savelberg, H. H. C. M., Meijer, K., Kuipers, H., & van Loon, L. J. C. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.03150.x · Cited by 126
Yeap, B. B., Almeida, O. P., Hyde, Z., Norman, P. E., Chubb, S. A. P., Jamrozik, K., & Flicker, L. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0714 · Cited by 126
Axell, A.-M., MacLean, H. E., Plant, D. R., Harcourt, L. J., Davis, J. A., Jimenez, M., Handelsman, D. J., Lynch, G. S., & Zajac, J. D. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00058.2006 · Cited by 125
“4 production have demonstrated a dose-dependent response of lean body mass and leg strength to testosterone, in both young (5) and elderly (6) males.”
BackgroundOphoff, J., Van Proeyen, K., Callewaert, F., De Gendt, K., De Bock, K., Vanden Bosch, A., Verhoeven, G., Hespel, P., & Vanderschueren, D. (2009) · Endocrinology · doi:10.1210/en.2008-1509 · Cited by 123
Noone, J., Mucinski, J. M., DeLany, J. P., Sparks, L. M., & Goodpaster, B. H. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.025 · Cited by 128
Frailty, Sarcopenia, and Hormones
Morley, J. E., & Malmstrom, T. K. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.02.006 · Cited by 143
Diagnosis and Management of Anabolic Androgenic Steroid Use
Anawalt, B. D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01882 · Cited by 118
“dosage-dependent effect of AASs on muscle mass and strength (17, 18).”
BackgroundTestosterone, Sex Hormone–Binding Globulin, and Frailty in Older Men
Mohr, B. A., Bhasin, S., Kupelian, V., Araujo, A. B., O'Donnell, A. B., & McKinlay, J. B. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01121.x · Cited by 117
Self-citationTestosterone in Obesity, Metabolic Syndrome and Type 2 Diabetes
Stanworth, R. D., & Jones, T. H. (2008) · Frontiers of Hormone Research · doi:10.1159/000176046 · Cited by 118
Bhasin, S., Apovian, C. M., Travison, T. G., Pencina, K., Moore, L. L., Huang, G., Campbell, W. W., Li, Z., Howland, A. S., Chen, R., et al. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.0008 · Cited by 113
Self-citationDHEA enhances effects of weight training on muscle mass and strength in elderly women and men
Villareal, D. T., & Holloszy, J. O. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00100.2006 · Cited by 116
“Testosterone has an anabolic effect on skeletal muscle (3, 5, 30) and powerfully potentiates the effects of heavy resistance exercise on muscle mass and strength (37, 38).”
Lakshman, K. M., Bhasin, S., Corcoran, C., Collins‐Racie, L. A., Tchistiakova, L., Forlow, S. B., Ledger, K. S., Burczynski, M. E., Dorner, A. J., & LaVallie, E. R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.12.019 · Cited by 120
Self-citationIs It Time to Begin a Public Campaign Concerning Frailty and Pre-frailty? A Review Article
Sacha, J., Sacha, M., Soboń, J., Borysiuk, Z., & Feusette, P. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00484 · Cited by 114
“In this context, testosterone, the primary androgenic hormone in men, appears to play a critical role because it has a strong anabolic influence on skeletal muscle (Bhasin et al., 2005).”
BackgroundPhysiological elevation of endogenous hormones results in superior strength training adaptation
Rønnestad, B. R., Nygaard, H., & Raastad, T. (2011) · European Journal of Applied Physiology · doi:10.1007/s00421-011-1860-0 · Cited by 112
Why Is Androgen Replacement in Males Controversial?
Cunningham, G. R., & Toma, S. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0266 · Cited by 111
“Libido, erectile function, and mood seem to be improved with levels in the low normal range (121), whereas skeletal muscle responds in a dose-responsive manner in younger and older men (55).”
BackgroundAge-related bone loss and sarcopenia in men
Laurent, M. R., Dedeyne, L., Dupont, J., Mellaerts, B., Dejaeger, M., & Gielen, E. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.01.006 · Cited by 120
Henderson, G. C., Dhatariya, K., Ford, G. C., Klaus, K. A., Basu, R., Rizza, R. A., Jensen, M. D., Khosla, S., O'Brien, P., & Nair, K. S. (2009) · The FASEB Journal · doi:10.1096/fj.08-117200 · Cited by 111
Higher Testosterone Levels Are Associated with Less Loss of Lean Body Mass in Older Men
LeBlanc, E. S., Wang, P. Y., Lee, C. G., Barrett-Connor, E., Cauley, J. A., Hoffman, A. R., Laughlin, G. A., Marshall, L. M., & Orwoll, E. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0312 · Cited by 108
Lunenfeld, B., Saad, F., & Hoesl, C. E. (2005) · The Aging Male · doi:10.1080/13685530500163416 · Cited by 122
“With low frequency of adverse events and significant gains in fat-free mass and muscle strength, a testosterone dose of 125 mg was found to be best in older men [107].”
BackgroundAging and Declining Testosterone: Past, Present, and Hopes for the Future
Zirkin, B. R., & Tenover, J. L. (2012) · Journal of Andrology · doi:10.2164/jandrol.112.017160 · Cited by 108
“At replacement doses in the normal range, muscle of older men responds similarly to that of young men (Bhasin et al, 2005).”
BackgroundSex hormones and skeletal muscle weakness
Sipilä, S., Narici, M., Kjaer, M., Pöllänen, E., Atkinson, R. A., Hansen, M., & Kovanen, V. (2013) · Biogerontology · doi:10.1007/s10522-013-9425-8 · Cited by 106
“…shown to provide a sustained release delivery system which mimics the natural hormonal profile for healthy men (Swerdloff et al. 2000) which is perhaps of use in treating those where avoiding the risk of adverse events associated with supraphysiological levels (Bhasin et al. 2005) is paramount.”
Fundamental Concepts Regarding Testosterone Deficiency and Treatment
Morgentaler, A., Zitzmann, M., Traish, A. M., Fox, A. W., Jones, T. H., Maggi, M., Arver, S., Aversa, A., Chan, J. C. N., Dobs, A. S., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.007 · Cited by 118
Clark, R. V., Wald, J. A., Swerdloff, R. S., Wang, C., Wu, F. C. W., Bowers, L. D., & Matsumoto, A. M. (2019) · Clinical Endocrinology · doi:10.1111/cen.13840 · Cited by 103
Tezze, C., Sandri, M., & Tessari, P. (2023) · Nutrients · doi:10.3390/nu15184073 · Cited by 129
Lakshman, K. M., Kaplan, B., Travison, T. G., Basaria, S., Knapp, P. E., Singh, A. B., LaValley, M. P., Mazer, N. A., & Bhasin, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0102 · Cited by 102
“Using blood samples and data from our previously published testosterone dose-response studies in young and older men (14, 15), we determined the effects of age, body composition, and testosterone dose on E2:T and DHT:T ratios.”
BackgroundMethodInfluentialSelf-citationTestosterone and glucose metabolism in men: current concepts and controversies
Grossmann, M. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0393 · Cited by 100
Borst, S. E., Yarrow, J. F., Conover, C. F., Nseyo, U., Meuleman, J. R., Lipinska, J. A., Braith, R. W., Beck, D. T., Martin, J. S., Morrow, M., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00592.2013 · Cited by 98
“A single preliminary report indicates that 200 mg im testosterone enanthate (TE) biweekly plus 5 mg finasteride/day improved total body fat-free mass and lumbar spine and hip BMD and lessened the prostate enlargement resulting from TE alone in older hypogonadal men.”
BackgroundInfluential
Metadata
- Authors
- Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Mac, R. P., Lee, M., Yarasheski, K. E., Sinha-Hikim, I., Dzekov, C., Dzekov, J., Magliano, L., & Storer, T. W.
- Affiliations
- University of California, Los Angeles (US)
- Charles R. Drew University of Medicine and Science (US)
- Washington University in St. Louis (US)
- El Camino College (US)
- Corresponding author
- Bhasin, Shalender
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-02
- Volume
- 90
- Issue
- 2
- Pages
- 678-688
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2133467178
- Cited by
- 544
- References
- 73
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 23 · 2023: 16 · 2022: 30 · 2021: 13 · 2020: 19 · 2019: 17 · 2018: 30 · 2017: 28 · 2016: 17 · 2015: 19 · 2014: 22 · 2013: 29 · 2012: 22
- FWCI
- 28.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p41rr000954-34, 5u01dk054047-06)
- National Institute on Aging (1R01 AG-14369-01, R01AG014369)
- National Institute of General Medical Sciences (GM-00425)
- National Institute of Diabetes and Digestive and Kidney Diseases (1R01 DK 59627-01, U01-DK-54047, R01DK049296, 2R01DK49296-02A, R01DK059627)
- National Center for Research Resources (G12 RR 03026, P41-RR000954, P20RR11145, 5P41-RR-000954, G12RR003026, P20RR011145)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD041748, R01HD043348)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- older men, androgen response, skeletal muscle, fat-free mass, fat mass, muscle strength, sexual function, mood, visuospatial cognition, GnRH agonist, testosterone replacement therapy, aging, hemoglobin response, adverse effects, treatment discontinuation
- MeSH terms
- Adult, Age Factors, Aged, Aging, Energy Intake, Exercise Test, Humans, Luteinizing Hormone, Male, Middle Aged, Sexual Behavior, Sex Hormone-Binding Globulin, Testosterone, Leuprolide, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.